Introduction of Lamivudine for the Treatment of Chronic Hepatitis B: Expected Clinical and Economic Outcomes Based on 4-Year Clinical Trial Data

Journal of Gastroenterology and Hepatology- United Kingdom

doi 10.1046/j.1440-1746.2002.02673.x

Full Text

Abstract

Available in

Categories

Gastroenterology

Date

February 1, 2002

Authors

DAVID TOGNARINI

Publisher

Wiley

Related search

Tenofovir Alafenamide in the Treatment of Chronic Hepatitis B Virus Infection: Rationale and Clinical Trial Evidence

Therapeutic Advances in Gastroenterology

Gastroenterology

English

Lamivudine for the Treatment of Membranous Glomerulopathy Secondary to Chronic Hepatitis B Infection

Canadian Journal of Gastroenterology

English

Lamivudine Treatment Can Restore T Cell Responsiveness in Chronic Hepatitis B.

Journal of Clinical Investigation

English

Prediction of Clinical Outcomes in Hepatitis B E Antigen Negative Chronic Hepatitis B Patients With Elevated Hepatitis B Virus DNA Levels

Multidisciplinary

English

Effect of Lamivudine Treatment on Survival of 309 North American Patients Awaiting Liver Transplantation for Chronic Hepatitis B

Liver Transplantation

Transplantation

English

Association of Virological Breakthrough and Clinical Outcomes in Entecavir-Treated HBeAg-positive Chronic Hepatitis B

Multidisciplinary

English

Associations of Chemokine System Polymorphisms With Clinical Outcomes and Treatment Responses of Chronic Hepatitis C

Gastroenterology

Gastroenterology

English

Pin38 - Clinical and Economic Impact of the Treatment of Chronic Hepatitis C in Prison Inmates in Spain

Value in Health

Occupational Health

English

Clinical Advances in Fibrosis Progression of Chronic Hepatitis B and C

Journal of Clinical and Translational Hepatology

English